Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne

Duchenne Muscular Dystrophy (DMD) is a severe muscle disorder caused by lack of dystrophin. Predictive biomarkers able to anticipate response to the therapeutic treatments aiming at dystrophin re-expression are lacking. The objective of this study is to investigate Matrix Metalloproteinase-9 (MMP-9)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lourbakos, A., Yau, N., de Bruijn, P., Hiller, M., Kozaczynska, K., Jean-Baptiste, R., Reza, M., Wolterbeek, R., Koeks, Z., Ayoglu, B., de Klerk, D., Campion, G., Zaharieva, I., Nadarajah, V. D., Nilsson, P., Al-Khalili Szigyarto, C., Muntoni, F., Lochmüller, H., Verschuuren, J. J., Goemans, N., Tulinius, M., Niks, E. H., de Kimpe, S., Aartsma-Rus, A., ’t Hoen, Peter A. C., Spitali, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738430/
https://www.ncbi.nlm.nih.gov/pubmed/29263366
http://dx.doi.org/10.1038/s41598-017-17982-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738430/
https://www.ncbi.nlm.nih.gov/pubmed/29263366
http://dx.doi.org/10.1038/s41598-017-17982-y

Ejemplares similares